The risk of breast cancer in women with a BRCA1 mutation from North America and Poland
Open Access
- 10 August 2011
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 131 (1) , 229-234
Abstract
Women with a BRCA1 mutation face a high lifetime risk of breast cancer. It is unknown to what extent environmental factors modify the inherent genetic risk. If women from different countries, but with similar mutations, experience different levels of cancer risk, nongenetic risk modifiers are likely to be present. Study subjects were a cohort of 1477 women with a BRCA1 mutation, from Canada (n = 358), the United States (n = 256) and Poland (n = 863). The women were followed for a mean of 4.3 years and 130 incident cases of breast cancer were recorded. Annual cancer incidence rates were calculated, and based on these, penetrance curves were constructed for women from North America and Poland. In a Cox proportional hazards model, residence in Poland, versus North America, was associated with an adjusted hazard ratio of 0.54 (95% CI 0.34‐0.86; p = 0.01). The risk of breast cancer to age 70 was estimated to be 49% for women from Poland and 72% for women from North America. Among women with BRCA1 mutations, the risk of breast cancer in women who reside in Poland is less than that of women who reside in North America. The reasons for the difference are unknown, but this observation suggests that environmental factors or genetic modifiers are important in determining risk.Keywords
This publication has 12 references indexed in Scilit:
- Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation CarriersJNCI: Journal of the National Cancer Institute, 2008
- Effect of Chest X-Rays on the Risk of Breast Cancer Among BRCA1/2 Mutation Carriers in the International BRCA1/2 Carrier Cohort Study: A Report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators’ GroupJournal of Clinical Oncology, 2006
- Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control studyThe Lancet Oncology, 2006
- Breast Cancer Risk Following Bilateral Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: An International Case-Control StudyJournal of Clinical Oncology, 2005
- Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersCancer Causes & Control, 2005
- Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studiesJournal of Medical Genetics, 2005
- A high proportion of founder BRCA1 mutations in Polish breast cancer familiesInternational Journal of Cancer, 2004
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesThe American Journal of Human Genetics, 2003
- Oral Contraceptives and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation CarriersJNCI: Journal of the National Cancer Institute, 2002
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesThe American Journal of Human Genetics, 1998